AUG 25, 2015 11:36 PM PDT

Tumor-Suppressing Protein

WRITTEN BY: Ilene Schneider
Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have led an international group of researchers in establishing the structure of a tumor suppressing protein, PTEN, according to a press release from Carnegie Mellon, as reported in Bioscience Technology. Their findings provide new insights into how the protein regulates cell growth and how mutations in the gene that encodes the protein can lead to cancer. Their findings are published online in Structure, and will appear in the October 6 issue.
 
Phosphatase and tensin homolog (PTEN), a known tumor suppressing protein, is encoded by the PTEN gene. When PTEN is expressed normally, it acts as an enzyme at the cell membrane, triggering a complex biochemical reaction that regulates the cell cycle and keeps cells from growing or dividing in an unregulated manner. Every cell in the body has two copies of the PTEN gene, one from each parent. If there is a mutation in one or both of the PTEN genes, it interferes with the protein’s enzymatic activity and interferes with its tumor suppressing ability.
An activated PTEN dimer that contains two non-mutant proteins (A) can transform the functional lipid (D) on the cellular membrane (E) into a chemical form that tunes down cancer predilection. Dimers that contain a mutated protein (B) or PTEN monomers cannot transform the functional lipid. 
According to Lösche, who seeks to understand the structure and function of cell membranes and membrane proteins, “Membrane-incorporated and membrane-associated proteins like PTEN make up one-third of all proteins in our body. Many important functions in health and disease depend on their proper functioning. Despite PTEN’s importance in human physiology and disease, there is a critical lack of understanding of the complex mechanisms that govern its activity.”
 
Researchers led by Pier Paolo Pandolfi at Harvard Medical School recently discovered that PTEN’s tumor suppressing activity gets elevated when two copies of the protein bind together, forming a dimeric protein. Lösche, a professor of physics and biomedical engineering at Carnegie Mellon, believes that PTEN dimerization could help researchers to understand an individual’s susceptibility for PTEN-sensitive tumors. To reveal the way in which dimerization improves PTEN’s ability to stop tumor development, researchers needed to determine the protein’s dimeric structure. Protein structure is usually identified with crystallography, but attempts to use that method with the PTEN dimer had been unsuccessful.

Lösche’s group used small-angle X–ray scattering (SAXS) to gains information about protein structure by scattering X-rays through a solution containing the protein. The researchers used computer modeling to establish the dimer’s structure. They discovered that in the PTEN dimers, the C-terminal tails of the two proteins might bind the protein bodies in a cross-wise way, making them more stable. Thus, they can interact more efficiently with the cell membrane, regulate cell growth and restrain tumor formation. With more knowledge about the structure of the PTEN dimer, researchers can use molecular biology tools to study the atomic-scale mechanisms of tumor formation facilitated by PTEN mutations. They hope that their findings will provide a new direction for cancer therapeutics.
 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 08, 2020
Genetics & Genomics
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
NOV 08, 2020
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
Researchers have found that drug-resistant bacteria can hang around even after deep cleaning. They used genome sequencin ...
DEC 21, 2020
Genetics & Genomics
Tracing the Evolution of a Deadly Microbe
DEC 21, 2020
Tracing the Evolution of a Deadly Microbe
Salmonella are human & animal bacterial pathogens that are found everywhere. When the bacterium infects a person, it cau ...
DEC 21, 2020
Cell & Molecular Biology
Mutagens May Be Having a Bigger Effect Than We Knew
DEC 21, 2020
Mutagens May Be Having a Bigger Effect Than We Knew
New research has suggested that our DNA is more susceptible to mutagenic influences than we've appreciated. While organi ...
JAN 05, 2021
Genetics & Genomics
Integrator: A New Type of Transcriptional Control is Discovered
JAN 05, 2021
Integrator: A New Type of Transcriptional Control is Discovered
The study of the genome once seemed like a straightforward process: a specific short sequence of three nucleotide bases ...
JAN 10, 2021
Genetics & Genomics
Did Sleep Precede the Brain?
JAN 10, 2021
Did Sleep Precede the Brain?
The longer we stay awake without sleeping, the more difficult it can become to think straight. But our functioning is re ...
JAN 15, 2021
Genetics & Genomics
Rare Quadruple Helix DNA Found in Live Human Cells
JAN 15, 2021
Rare Quadruple Helix DNA Found in Live Human Cells
Many people picture the classic double-stranded helix when picturing a molecule of DNA, but DNA is also capable of formi ...
Loading Comments...